Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret (ANGEN)

Istanbul
Currency in TRY
11.22
+0.04(+0.36%)
Closed
ANGEN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
11.1811.66
52 wk Range
10.3121.12
Key Statistics
Edit
Bid/Ask
11.21 / 11.22
Prev. Close
11.22
Open
11.24
Day's Range
11.18-11.66
52 wk Range
10.31-21.12
Volume
6.68M
Average Volume (3m)
10.99M
1-Year Change
-9.15%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANGEN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market
No news in this category
Looks like there are no results in this news category

Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret Company Profile

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cytomegalovirus, crimean-congo hemorrhagic fever, novel coronavirus (2019-NCoV)/SARS-CoV-2, epstein-barr virus, hepatitis B, hepatitis C, hepatitis D, herpes simplex virus, human immunodeficiency virus, human papillomavirus, JC and BK polyomaviruses, malaria, measles, meningitis, respiratory infection, parvovirus B19, torque teno virus, toxoplasmosis, tuberculosis, ureaplasma, and west nile virus diseases, as well as factor II, factor V leiden, and methylene-tetra-hydro-folate-reductase mutation diseases. Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is headquartered in Istanbul, Turkey.

Compare ANGEN to Peers and Sector

Metrics to compare
ANGEN
Peers
Sector
Relationship
P/E Ratio
−11.3x−0.6x−0.5x
PEG Ratio
1.05−0.020.00
Price/Book
1.6x0.8x2.6x
Price / LTM Sales
4.7x11.3x3.0x
Upside (Analyst Target)
-209.7%57.3%
Fair Value Upside
Unlock2.3%10.5%Unlock

Earnings

Latest Release
May 08, 2023
EPS / Forecast
0.11 / --
Revenue / Forecast
27.14M / --
EPS Revisions
Last 90 days

FAQ

What Is the Anatolia Tanı ve Biyoteknoloji (ANGEN) Stock Price Today?

The Anatolia Tanı ve Biyoteknoloji stock price today is 11.22

What Stock Exchange Does Anatolia Tanı ve Biyoteknoloji Trade On?

Anatolia Tanı ve Biyoteknoloji is listed and trades on the Istanbul stock exchange.

What Is the Stock Symbol for Anatolia Tanı ve Biyoteknoloji?

The stock symbol for Anatolia Tanı ve Biyoteknoloji is "ANGEN."

Does Anatolia Tanı ve Biyoteknoloji Pay Dividends? What’s The Current Dividend Yield?

The Anatolia Tanı ve Biyoteknoloji dividend yield is 4.49%.

What Is the Anatolia Tanı ve Biyoteknoloji Market Cap?

As of today, Anatolia Tanı ve Biyoteknoloji market cap is 2.47B.

What is Anatolia Tanı ve Biyoteknoloji Earnings Per Share?

The Anatolia Tanı ve Biyoteknoloji EPS is -0.995.

From a Technical Analysis Perspective, Is ANGEN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.